Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mobi724 Global Solutions Inc V.MOS

Alternate Symbol(s):  MOBIF

Mobi724 Global Solutions Inc. is a fintech company. It provides a fintech platform which enables banks and merchants to offer real-time payment card-linked incentives, in a white-label format. It operates through the Smart Transactions processing segment. It offers banks and merchants an end-to-end technology platform and fully integrated data-driven Business Intelligence (BI) and Artificial Intelligence (AI) powered solutions that work with any digital payment method, at the point of sale, both online and physically. Its solutions portfolio includes Card-Linked and Artificial Intelligence. Its solutions can be deployed on any digital payment method and network, with a third-party CRM, a rewards catalogue enabler, or a mobile app. Its APIs provides payment card issuers and networks with a secure and flexible integration process. It provides cardholder lifecycle management and payment card portfolio optimization capabilities through AI-enhanced, transaction-driven engagement solutions.


TSXV:MOS - Post by User

Comment by NUCLEARon Aug 16, 2000 12:39am
348 Views
Post# 2329905

RE: Bought more......

RE: Bought more......The primary reason that I bought this stock is that a colleague of mine who happens to be a respected nephrologist whose specialty is dialysis and kidney transplantation thought this product was the greatest thing invented for ICU patients. In fact, he went out and bought a sh*t load at under 60 cents before the rise to $1.50. I believe he's still holding. His faith in the product gave me the confidence to get in on the action myself. Some other specialists at my hospital have also invested heavily. This includes a pathologist, a cardiologist, and an endocrinologist. In short, it appears the medical community thinks this brush is cost effective and of great use in critical care patients. Hope this helps. NUCLEAR
Bullboard Posts